Moleculin Biotech, Inc.
MBRX
$2.41
-$0.06-2.43%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.97% | 3.82% | -0.10% | -4.78% | -9.23% |
| Depreciation & Amortization | -46.40% | -28.57% | -13.85% | -6.87% | -3.85% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.35% | -5.77% | -16.27% | -8.25% | -7.32% |
| Operating Income | -4.35% | 5.77% | 16.27% | 8.25% | 7.32% |
| Income Before Tax | -48.13% | -26.80% | -85.53% | -29.91% | -0.59% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -48.13% | -26.80% | -85.53% | -29.91% | -0.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.13% | -26.80% | -85.53% | -29.91% | -0.59% |
| EBIT | -4.35% | 5.77% | 16.27% | 8.25% | 7.32% |
| EBITDA | -4.60% | 5.66% | 16.28% | 8.26% | 7.34% |
| EPS Basic | 75.76% | 73.86% | 68.88% | 61.71% | 47.81% |
| Normalized Basic EPS | 76.04% | 73.88% | 68.88% | 61.71% | 47.81% |
| EPS Diluted | 75.76% | 73.86% | 68.88% | 61.71% | 47.81% |
| Normalized Diluted EPS | 76.04% | 73.88% | 68.88% | 61.71% | 47.81% |
| Average Basic Shares Outstanding | 927.60% | 760.10% | 528.12% | 276.09% | 144.41% |
| Average Diluted Shares Outstanding | 927.60% | 760.10% | 528.12% | 276.09% | 144.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |